Firering Strategic Minerals: From explorer to producer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGlaxosmithkline Share News (GSK)

Share Price Information for Glaxosmithkline (GSK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,613.50
Bid: 1,613.00
Ask: 1,614.00
Change: -3.00 (-0.19%)
Spread: 1.00 (0.062%)
Open: 1,619.50
High: 1,620.50
Low: 1,612.00
Prev. Close: 1,616.50
GSK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FTSE 100 movers: Lloyds takes top spot after strong Q1, TSB float

Thu, 01st May 2014 14:32

Domestic lender Lloyds rose into the top spot after saying that underlying profits rose by over a fifth in the first quarter and it continues to expect to apply to regulators in the second half to restart dividend payments. That came as it announced TSB bank is due to float in London before the end of June, selling at least a 25 per cent stake of the recovering business. Most of Lloyds's key financial metrics continued to 'appreciate measurably' in the first quarter, according to Hargreaves Lansdown Stockbrokers. "Lloyds is often seen as a proxy for the UK economy, and although they are inextricably linked, both are beginning to prosper after a long period of austerity," said Head of Equities Richard Hunter.Profits at oil and gas company BG Group rose as it regained losses incurred earlier in the week, which came on the back of lower production volumes and higher costs, as well as the surprise exit of its Chief Executive.Earnings fell 2.4% at BSkyB in the third quarter despite a rise in revenues, but continued investment in connected television services was repaid with better-than-expected new subscriptions, pushing shares higher throughout today's session.Communications services giant WPP was higher after announcing it has acquired Canadian creative digital marketing agency Twist Image Multimedia. Drugs giant GlaxoSmithKline rose after it announced that the US Food and Drug Administration (FDA) has approved its Incruse medication, Ellipta.Meanwhile, Sainsbury, Tesco and Morrison were all notable fallers this afternoon after the latter unveiled plans to slash the price of 1,2000 products by as much as 60% in an effort to take a greater slice of the market share. As many as 40% of the products will be own-brand items. Broker Bernstein said the size of the move marked "a big departure" and said the company was "dropping the ultimate bomb". Scottish engineering group Weir declined after Numis Securities downgraded its rating for the stock from 'add' to 'hold', saying that it sees little upside after the stock's recent strong run. That came after the group posted in line trading in the last four months.Engine maker Rolls-Royce fell into the red after saying that full-year revenues and profits are likely to be hit by foreign exchange headwinds with underlying results flat.FTSE 100 - RisersLloyds Banking Group (LLOY) 79.00p +4.83%Hargreaves Lansdown (HL.) 1,218.00p +4.10%BG Group (BG.) 1,235.50p +3.13%Aggreko (AGK) 1,623.00p +2.92%Royal Bank of Scotland Group (RBS) 306.90p +2.71%British Sky Broadcasting Group (BSY) 900.50p +2.33%Johnson Matthey (JMAT) 3,342.00p +2.11%Reckitt Benckiser Group (RB.) 4,868.00p +1.95%International Consolidated Airlines Group SA (CDI) (IAG) 411.90p +1.93%Royal Mail (RMG) 539.50p +1.89%FTSE 100 - FallersSainsbury (J) (SBRY) 323.10p -3.75%Weir Group (WEIR) 2,603.00p -3.23%Tesco (TSCO) 284.45p -2.90%Vodafone Group (VOD) 218.45p -2.46%Antofagasta (ANTO) 770.00p -2.16%Randgold Resources Ltd. (RRS) 4,690.00p -1.88%Rolls-Royce Holdings (RR.) 1,031.00p -1.81%Morrison (Wm) Supermarkets (MRW) 197.90p -1.49%Fresnillo (FRES) 839.00p -1.47%Anglo American (AAL) 1,561.50p -1.30%NR
More News
17 Jan 2024 07:31

GSK raises $1.24 bln from latest Haleon stake sale

Jan 17 (Reuters) - GSK has raised 978 million pounds ($1.24 billion) from a discounted sale of a stake in its spun-off consumer healthcare business Haleon, the British drugmaker said on Wednesday.

Read more
16 Jan 2024 17:04

GSK to sell GBP1 billion worth of Haleon shares as trims stake again

(Alliance News) - GSK PLC on Tuesday said it intends to sell around GBP1.00 billion worth of shares in Haleon PLC, as it continues to reduce its shareholding in the Weybridge, Surrey-based consumer healthcare spin-off.

Read more
16 Jan 2024 09:14

LONDON BROKER RATINGS: UBS raises GSK and cuts AstraZeneca

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning:

Read more
16 Jan 2024 08:15

UBS downgrades AstraZeneca to 'sell'

(Sharecast News) - UBS has downgraded AstraZeneca and upgraded rival GSK as part of its latest review of the European pharmaceutical sector.

Read more
16 Jan 2024 07:37

LONDON BRIEFING: UK jobless rate sticks at 4.2% but pay growth slows

(Alliance News) - Stocks in London are called to open lower on Tuesday, following data showing that the UK jobless rate was unchanged at 4.2% as pay growth slowed.

Read more
15 Jan 2024 08:42

Zantac fallout unfairly weighing on GSK, says Shore Capital

(Sharecast News) - Shore Capital has raised its target price and maintained a positive stance on biopharma giant GSK, saying that worries about the potential cost of Zantac litigation are unfairly weighing on the stock.

Read more
10 Jan 2024 09:35

LONDON BROKER RATINGS: BofA cuts Ashtead; UBS likes 3i Group

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning and Tuesday:

Read more
10 Jan 2024 08:25

GSK says Nucala gets green light in China for asthma treatment

(Alliance News) - GSK PLC on Wednesday said Nucala has been approved in China for the treatment of severe asthma.

Read more
10 Jan 2024 07:22

GSK's Nucala gets fresh approval in China

(Sharecast News) - GSK announced on Wednesday that the China National Medical Products Administration (NMPA) has granted approval for 'Nucala', or mepolizumab, as an add-on maintenance treatment for severe eosinophilic asthma in adults and adolescents aged 12 years and older.

Read more
9 Jan 2024 16:22

London close: Stocks finish red after choppy session

(Sharecast News) - London stocks had turned back into the red by the close on Tuesday, with recruitment firms and asset managers pacing the declines after some disappointing corporate updates.

Read more
9 Jan 2024 08:03

TOP NEWS: GSK to buy Aiolos Bio for up to USD1.4 billion

(Alliance News) - GSK PLC on Tuesday said it will acquire asthma drug developer Aiolos Bio Inc for USD1 billion upfront, as well as up to USD400 million in certain success-based milestone payments.

Read more
9 Jan 2024 07:16

GSK buys respiratory drug maker Aiolos for $1bn

(Sharecast News) - GSK said it was buying Aiolos, a clinical-stage biopharmaceutical company focused on treatment of respiratory and inflammatory conditions, for up to $1.4bn (£1.1bn).

Read more
8 Jan 2024 23:39

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 23:00

Pfizer to remain aggressive on obesity market after setback

NEW YORK, Jan 8 (Reuters) - Pfizer will remain aggressive in trying to break into the lucrative obesity market, even after dropping a high profile weight-loss drug candidate late last year due to strong side effects, Chief Executive Albert Bourla said on Monday.

Read more
8 Jan 2024 19:02

Moderna says it hit its 2023 COVID vaccine sales goal

Jan 8 (Reuters) - Moderna on Monday said its 2023 COVID vaccine sales would be around $6.7 billion, coming in above the lower end of its full-year forecast, and reiterated its goal of returning to sales growth in 2025.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.